Kappa‐opioid receptor‐mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice
暂无分享,去创建一个
[1] Yongxiang Wang,et al. Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A , 2020, Neural plasticity.
[2] Yong-Jing Gao,et al. Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential. , 2020, Pharmacology & therapeutics.
[3] Yi-ze Li,et al. Spinal CCL1/CCR8 regulates phosphorylation of GluA1-containing AMPA receptor in postoperative pain after tibial fracture and orthopedic surgery in mice , 2020, Neuroscience Research.
[4] Yongxiang Wang,et al. Bulleyaconitine A Exerts Antianxiety and Antivisceral Hypersensitivity Effects , 2020, Frontiers in Pharmacology.
[5] Zhiheng Chen,et al. Dynorphin activation of kappa opioid receptor promotes microglial polarization toward M2 phenotype via TLR4/NF-κB pathway , 2020, Cell & Bioscience.
[6] A. Gutiérrez-Fernández,et al. Dual dose-related effects evoked by CCL4 on thermal nociception after gene delivery or exogenous administration in mice. , 2020, Biochemical pharmacology.
[7] Y. Yamaguchi,et al. Gadolinium causes M1 and M2 microglial apoptosis after intracerebral haemorrhage and exerts acute neuroprotective effects , 2020, The Journal of pharmacy and pharmacology.
[8] M. García-Domínguez,et al. The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System , 2019, Cellular and Molecular Neurobiology.
[9] Jiao Guo,et al. M2b macrophage polarization and its roles in diseases , 2018, Journal of leukocyte biology.
[10] Y. Qadri,et al. Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain , 2018, Neuron.
[11] R. Cernuda-Cernuda,et al. The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4+ Lymphocytes and Met-Enkephalin , 2018, Molecular Neurobiology.
[12] M. Tsuda,et al. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential , 2018, Nature Reviews Neuroscience.
[13] C. Pert,et al. Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1/CCR8 , 2017, Neurochemistry International.
[14] A. Piotrowska,et al. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target – Evidence from a mouse diabetic neuropathy model , 2017, International immunopharmacology.
[15] L. Ferreira,et al. Anti-Inflammatory Strategy for M2 Microglial Polarization Using Retinoic Acid-Loaded Nanoparticles , 2017, Mediators of inflammation.
[16] R. Cernuda-Cernuda,et al. Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice , 2017, Brain, Behavior, and Immunity.
[17] Yongxiang Wang,et al. Molecular signaling underlying bulleyaconitine A (BAA)-induced microglial expression of prodynorphin , 2017, Scientific Reports.
[18] Yongxiang Wang,et al. Aconitum-Derived Bulleyaconitine A Exhibits Antihypersensitivity Through Direct Stimulating Dynorphin A Expression in Spinal Microglia. , 2016, The journal of pain : official journal of the American Pain Society.
[19] C. McPherson,et al. Microglial M1/M2 polarization and metabolic states , 2016, British journal of pharmacology.
[20] A. Piotrowska,et al. Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy , 2015, Neural plasticity.
[21] Y. Iwakura,et al. Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages , 2014, PloS one.
[22] R. Ji,et al. Microglia and Spinal Cord Synaptic Plasticity in Persistent Pain , 2013, Neural plasticity.
[23] M. Noda,et al. Effects of chemokine (C-C motif) ligand 1 on microglial function. , 2013, Biochemical and biophysical research communications.
[24] M. Kido,et al. CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury , 2013, Cell Death and Disease.
[25] B. Fitzsimmons,et al. Spinal astrocytes produce and secrete dynorphin neuropeptides , 2013, Neuropeptides.
[26] N. Kiguchi,et al. CC‐chemokine ligand 4/macrophage inflammatory protein‐1β participates in the induction of neuropathic pain after peripheral nerve injury , 2012, European journal of pain.
[27] Tamara Boto,et al. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice. , 2011, European journal of pharmacology.
[28] A. Hidalgo,et al. Involvement of glutamate NMDA and AMPA receptors, glial cells and IL-1β in the spinal hyperalgesia evoked by the chemokine CCL2 in mice , 2011, Neuroscience Letters.
[29] Y. Day,et al. Inflammation Confers Dual Effects on Nociceptive Processing in Chronic Neuropathic Pain Model , 2011, Anesthesiology.
[30] N. Murphy,et al. Enkephalins, dynorphins, and β‐endorphin in the rat dorsal horn: An immunofluorescence colocalization study , 2009, The Journal of comparative neurology.
[31] H. Rittner,et al. The other side of the medal: How chemokines promote analgesia , 2008, Neuroscience Letters.
[32] F. Schaefer,et al. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. , 2007, The American journal of pathology.
[33] Chongguang Chen,et al. Dynorphin peptides differentially regulate the human κ opioid receptor , 2007 .
[34] Yong Liu,et al. CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and the dentate gyrus during and after pilocarpine‐induced status epilepticus , 2007, Journal of neurochemistry.
[35] H. Rittner,et al. Chemokines and pain. , 2006, Current opinion in investigational drugs.
[36] R. Coggeshall. Fos, nociception and the dorsal horn , 2005, Progress in Neurobiology.
[37] H. Rittner,et al. Leukocytes in the regulation of pain and analgesia , 2005, Journal of leukocyte biology.
[38] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[39] A. Iellem,et al. Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells , 2001, The Journal of experimental medicine.
[40] M. Baggiolini,et al. Identification of CCR8, the Receptor for the Human CC Chemokine I-309* , 1997, The Journal of Biological Chemistry.
[41] T. Bonner,et al. Brief Definitive Report Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309 , 2022 .
[42] R. Leak,et al. Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.
[43] W. Pardridge,et al. Blood-brain barrier delivery. , 2007, Drug discovery today.
[44] Chongguang Chen,et al. Dynorphin peptides differentially regulate the human kappa opioid receptor. , 2007, Life sciences.
[45] H. Akil,et al. The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. , 1995, Brain research.